Response Genetics
RGDXQ · OTC
$0.00−$0.00 (−50.00%)TodayMarket closed ·
No price history for this range.
Key indicators
RGDXQ profitability and balance sheet ratios
EPS -$0.1036 in Mar 2015, against -$0.0905 a year earlier.
| Period | EPS |
|---|---|
| Jun 2013 | -$0.0396 |
| Sep 2013 | -$0.0821 |
| Dec 2013 | -$0.3864 |
| Mar 2014 | -$0.0905 |
| Jun 2014 | -$0.081 |
| Sep 2014 | -$0.2656 |
| Dec 2014 | -$0.0879 |
| Mar 2015 | -$0.1036 |
Income statement
No financial statements are reported for Response Genetics.
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | Sep 2014 | Dec 2014 | Mar 2015 |
|---|---|---|---|
| Total assets | $16.3M | $13.4M | $10.8M |
| Total liabilities | $14.3M | $14.6M | $15.7M |
| Shareholder equity | $2.0M | −$1.2M | −$4.9M |
| Cash and short-term investments | $6.0M | $2.2M | $1.7M |
| Total debt | $1.7M | $9.7M | $10.9M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.